Works matching DE "CONVERSION therapy"

Results: 361
    1
    2

    A Pathway to Spirituality.

    Published in:
    Psychiatry: Interpersonal & Biological Processes, 2005, v. 68, n. 4, p. 350, doi. 10.1521/psyc.2005.68.4.350
    By:
    • Shaw, Jon A.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1352262
    By:
    • San-Román-Gil, María;
    • Martínez-Delfrade, Iñigo;
    • Albarrán-Fernández, Víctor;
    • Guerrero-Serrano, Patricia;
    • Pozas-Pérez, Javier;
    • Chamorro-Pérez, Jesús;
    • Rosero-Rodríguez, Diana;
    • Sotoca-Rubio, Pilar;
    • Barrill-Corpa, Ana Maria;
    • Alia-Navarro, Víctor;
    • González-Merino, Carlos;
    • García-de-Quevedo-Suero, Coral;
    • López, Victoria;
    • Ruz-Caracue, Ignacio;
    • Perna-Monroy, Cristian;
    • Ferreiro-Monteagudo, Reyes
    Publication type:
    Article
    26
    27

    Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
    By:
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi;
    • Kawata, Kazuhito;
    • Kosaka, Hisashi
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Can We Change Sexual Orientation?

    Published in:
    Archives of Sexual Behavior, 2012, v. 41, n. 1, p. 121, doi. 10.1007/s10508-012-9922-x
    By:
    • Beckstead, A.
    Publication type:
    Article
    34
    35

    Peer Commentaries on Spitzer (2003).

    Published in:
    Archives of Sexual Behavior, 2003, v. 32, n. 5, p. 419, doi. 10.1023/A:102569951
    By:
    • Bancroft, John;
    • Beckstead, A. Lee;
    • Byrd, A. Dean;
    • Carlson, Helena M.;
    • Cohen, Kenneth M.;
    • Savin-Williams, Ritch C.;
    • Diamond, Lisa M.;
    • Drescher, Jack;
    • Friedman, Richard C.;
    • Gagnon, John H.;
    • Hartmann, Lawrence;
    • Herek, Gregory M.;
    • Hershberger, Scott L.;
    • Hill, Craig A.;
    • DiClementi, Jeannie D.;
    • Klein, Donald F.;
    • Krueger, Richard B.;
    • McConaghy, Nathaniel;
    • Nicolosi, Joseph;
    • Rind, Bruce
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Is 'conversion therapy' tortious?

    Published in:
    Legal Studies, 2022, v. 42, n. 1, p. 23, doi. 10.1017/lst.2021.28
    By:
    • Purshouse, Craig;
    • Trispiotis, Ilias
    Publication type:
    Article
    45
    46
    47
    48

    Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14250-5
    By:
    • Yalikun, Kugeluke;
    • Li, Zhongchao;
    • Zhang, Jianxin;
    • Chang, Zhibin;
    • Li, Mingming;
    • Sun, Zhicheng;
    • Liu, Zhaogang;
    • Yang, Yue;
    • Xu, Lei;
    • Li, Lei;
    • Zhang, Chengsheng;
    • Sun, Pengfei;
    • Zhong, Jingtao;
    • Cui, Kai;
    • Shi, Xuetao;
    • Zhang, Bo;
    • Zhao, Lei
    Publication type:
    Article
    49

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13648-5
    By:
    • Kodama, Yoshihisa;
    • Ueshima, Kazuomi;
    • Moriguchi, Michihisa;
    • Inaba, Yoshitaka;
    • Yamashita, Tatsuya;
    • Iwamoto, Hideki;
    • Ueno, Makoto;
    • Ogasawara, Sadahisa;
    • Kuzuya, Teiji;
    • Kodama, Takahiro;
    • Sato, Yozo;
    • Tada, Toshifumi;
    • Tsuchiya, Kaoru;
    • Nishiofuku, Hideyuki;
    • Yamakado, Koichiro;
    • Sone, Miyuki;
    • Ikeda, Masafumi;
    • Takehara, Tetsuo;
    • Hamano, Tetsutaro;
    • Kudo, Masatoshi
    Publication type:
    Article
    50

    Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13648-5
    By:
    • Kodama, Yoshihisa;
    • Ueshima, Kazuomi;
    • Moriguchi, Michihisa;
    • Inaba, Yoshitaka;
    • Yamashita, Tatsuya;
    • Iwamoto, Hideki;
    • Ueno, Makoto;
    • Ogasawara, Sadahisa;
    • Kuzuya, Teiji;
    • Kodama, Takahiro;
    • Sato, Yozo;
    • Tada, Toshifumi;
    • Tsuchiya, Kaoru;
    • Nishiofuku, Hideyuki;
    • Yamakado, Koichiro;
    • Sone, Miyuki;
    • Ikeda, Masafumi;
    • Takehara, Tetsuo;
    • Hamano, Tetsutaro;
    • Kudo, Masatoshi
    Publication type:
    Article